Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.
Leukemia. 1996 Jan;10(1):20-6.
PMID:8558932
Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia.
Iwafuchi H, Ito M.
Histopathology. 2019 Jan;74(2):239-247. doi: 10.1111/his.13721. Epub 2018 Oct 29.
PMID:30062702
Effect of Qinghuang Powder () Combined with Bupi Yishen Decoction () in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation.
Zhou QB, Yang XH, Wang HZ, Wang DX, Xu YG, Hu XM, Xu FQ, Ma R.
The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J, Belicková M, Krejcová H, Michalová K, Zilovcová S, Zemanová Z, Brezinová J, Sieglová Z.
Leuk Res. 2005 Apr;29(4):371-9. doi: 10.1016/j.leukres.2004.08.008. Epub 2004 Dec 22.
PMID:15725470
Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia.